SCHEMBL20475325

SCHEMBL20475325

Cc1cccc2nc3c(C)cccc3nc12

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.53
MAPT P10636 4/20 0.53
MAPK1 P28482 1/20 0.53
ACHE P22303 1/20 0.50
NQO2 P16083 4/20 0.48
NPC1 O15118 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
G6PD P11413 1/20 0.48
PKM P14618 1/20 0.48
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
HCRTR1 O43613 1/20 0.46
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CYP2A6 P11509 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31643056 1.00 RAB9A (0.53) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL183009 0.93 NQO2 (0.57) RAB9AMAPTMAPK1ACHENQO2
Bromide SCHEMBL11421481 0.91 NQO2 (0.55) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL8604288 0.87 MAPT (0.52) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL13271195 0.87 ACHE (0.75) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL12578240 0.85 RAB9A (0.49) RAB9AMAPTMAPK1NQO2NPC1
SCHEMBL2423180 0.84 TDP1 (0.52) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL10371728 0.84 TDP1 (0.48) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL31399980 0.84 TDP1 (0.52) RAB9AMAPTMAPK1ACHENQO2
SCHEMBL11399572 0.84 RAB9A (0.46) RAB9AMAPTMAPK1ACHENQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053205-B2 Phenazine derivatives as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2021-07-06 US disclosed
WO-2018152436-A1 PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF RESEARCH FOUNDATION, INCORPORATED (US) 2018-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053205-B2 Phenazine derivatives as antimicrobial agents ROS1, NOX4, PRDX3 RAB9A 1669/4885MAPT 2601/4885MAPK1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.